Madison, Connecticut
United States
40
2014-11-06
The entities that hold a legal rights for patent applications filed by inventor SMITH Roger A.:
Roger A. SMITH from Madison, US has applied for patents for these inventions. The list has both pending applications and granted patents:
OMEGA-CARBOXYARL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
#2 | 2012-10-25INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
#3 | 2012-07-12RAF KINASE INHIBITORS
#4 | 2012-06-14INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
#5 | 2012-06-07Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#6 | 2012-05-24Inhibition Of Raf Kinase Using Substituted Heterocyclic Ureas
#7 | 2012-02-28ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#8 | 2012-02-23INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
#9 | 2012-02-16OMEGA CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
#10 | 2011-04-19Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
#11 | 2010-03-11Raf Kinase Inhibitors
#12 | 2009-10-29Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
#13 | 2009-10-08Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
#14 | 2009-07-23NOVEL PYRIMIDOTHIENOINDAZOLES
#15 | 2009-05-07OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
#16 | 2009-04-14Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
#17 | 2009-04-09INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
#18 | 2008-12-04Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
#19 | 2008-10-30Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
#20 | 2008-08-14Inhibition Of Raf Kinase Using Quinolyl, Isoquinolyl Or Pyridyl Ureas
#21 | 2008-06-26Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#22 | 2008-05-08Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
#23 | 2008-04-01ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#24 | 2008-02-12Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
#25 | 2008-02-07Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
#26 | 2008-01-31ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
#27 | 2008-01-10Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
#28 | 2007-10-18INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS
#29 | 2007-06-26Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
#30 | 2006-07-04Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesity
#31 | 2006-06-08Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesity
#32 | 2006-03-23Hydroxamic acids useful in the treatment of hyper-proliferative disorders
#33 | 2006-01-26Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
#34 | 2005-11-17Raf kinase inhibitors
#35 | 2005-11-17Preparation and use of imidazole derivatives for treatment of obesity
#36 | 2005-11-01Preparation and use of imidazole derivatives for treatment of obesity
#37 | 2005-09-292,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
#38 | 2005-07-192,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
#39 | 2005-02-17Bicyclic urea derivatives useful in the treatment of cancer and other disorders
#40 | 2005-02-102-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
961827 ⎘